| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/16/2009 | WO2006031291A3 A novel class of therapeutic protein based molecules |
| 04/16/2009 | WO2006029184A3 Genes useful for diagnosing and monitoring inflammation related disorders |
| 04/16/2009 | WO2006028999A3 Assessment of ctla-4 polymorphisms in ctla-4 blockade therapy |
| 04/16/2009 | WO2006019876A3 Production of fusion proteins by cell-free protein synthesis |
| 04/16/2009 | WO2006019637A3 An intelligent nanomedicine integrating diagnosis and therapy |
| 04/16/2009 | WO2006014588A3 Nucleic acid end-labeling reagents |
| 04/16/2009 | WO2006009676A3 Compositions and methods for enzymatic decolorization of chlorophyll |
| 04/16/2009 | WO2006007432A3 Nucleic acid molecules encoding wrinkled1-like polypeptides and methods of use in plants |
| 04/16/2009 | WO2005121375A3 Detection of dna mismatches and oxidative lesions |
| 04/16/2009 | WO2005115477A3 Non-natural ribonuclease conjugates as cytotoxic agents |
| 04/16/2009 | WO2005084116A3 Calcium channel variants |
| 04/16/2009 | WO2005069994A3 Folate conjugates and complexes |
| 04/16/2009 | WO2005056761A3 REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi |
| 04/16/2009 | WO2005040356A3 Mutant p53 protein and uses thereof |
| 04/16/2009 | WO2005035713A3 Alternatively spliced variants of human cox1 |
| 04/16/2009 | WO2005021727A3 Isoform-specific targeting of splice variants |
| 04/16/2009 | WO2005021705A9 Citrus sesquiterpene synthase, methods of production and uses thereof |
| 04/16/2009 | WO2004074433A3 Rag polypeptides, nucleic acids, and their use |
| 04/16/2009 | US20090100549 Plant galactinol synthase homologs |
| 04/16/2009 | US20090100542 Promoter for epidermis-specific, pathogen-inducible transgenic expression in plants |
| 04/16/2009 | US20090100539 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline conditions |
| 04/16/2009 | US20090100534 Muscle lamin a/c interacting protein, gene encoding same, and uses therefor |
| 04/16/2009 | US20090099351 Nylon polyribonucleosides |
| 04/16/2009 | US20090099350 Instrument and method for nucleic acid isolation |
| 04/16/2009 | US20090099348 Nucleic acid encoding a novel ribonuclease having an amino acid sequence made up of a known amino acid sequence and an initial n-terminal residue |
| 04/16/2009 | US20090099124 Short interfering rna as an antiviral agent for hepatitis c |
| 04/16/2009 | US20090099123 Antisense microRNA and uses therefor |
| 04/16/2009 | US20090099120 For modulating the expression of genes associated with respiratory and pulmonary disease, such as cholinergic muscarinic receptor genes; nucleic acids with a pyrimidine modification |
| 04/16/2009 | US20090099119 RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/16/2009 | US20090099118 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/16/2009 | US20090099117 RNA INTERFERENCE MEDIATED INHIBITION OF MYOSTATIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/16/2009 | US20090099116 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/16/2009 | US20090099115 A chemically-modified nucleic acid molecule that comprises a sense strand with or without the 3' TT overhang, and a separate antisense strand with or without the 3' TT overhang; pyrimidine modification; cancer |
| 04/16/2009 | US20090099114 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/16/2009 | US20090099113 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/16/2009 | US20090099112 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/16/2009 | US20090099111 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/16/2009 | US20090099110 Antiviral oligonucleotides |
| 04/16/2009 | US20090099108 Oligonucleotide decoys and methods of use |
| 04/16/2009 | US20090099079 Novel Fungal Enzymes |
| 04/16/2009 | US20090099078 Nogo Receptor Antagonists |
| 04/16/2009 | US20090099075 Chimeric Keratin-Binding Effector Proteins |
| 04/16/2009 | US20090099073 Albumin Fusion Proteins |
| 04/16/2009 | US20090099072 Motif of the Beclin Protein Which Interacts with Anti-Apoptotic Members of the Bcl-2 Protein Family, and Uses |
| 04/16/2009 | US20090099069 Modulators of alpha-synuclein toxicity |
| 04/16/2009 | US20090099056 Protease Variants and Compositions |
| 04/16/2009 | US20090099043 Construction of pool of interfering nucleic acids covering entire RNA target sequence and related compositions |
| 04/16/2009 | US20090099040 Degenerate oligonucleotides and their uses |
| 04/16/2009 | US20090099028 Protein binding miniature proteins and uses thereof |
| 04/16/2009 | US20090098631 Novel glutamic acid decarboxylase (GAD) proteins and methods of use |
| 04/16/2009 | US20090098630 Fusion protein, gene related to fusion protein, vector, transformants, and anti-inflammatory medicinal composition |
| 04/16/2009 | US20090098614 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA |
| 04/16/2009 | US20090098611 Self-cleaving affinity tags and methods of use |
| 04/16/2009 | US20090098610 useful as a reagent for genetic engineering, DNA sequencing, labeling, site-directed mutagenesi; culturing a cell capable of producing a polypeptide, and collecting such polypeptide from the culture |
| 04/16/2009 | US20090098609 Il-2 fusion proteins with modulated selectivity |
| 04/16/2009 | US20090098608 Methods, systems and reagents for improved immunodetection |
| 04/16/2009 | US20090098605 MUTATED TRUNCATED mt-pfkA GENE FOR THE SYNTHESIS OF ACTIVE SHORTER FRAGMENT OF 6-PHOSPHOFRUCTO-1-KINASE |
| 04/16/2009 | US20090098602 nucleic acid sequence encoding mHKcel; used as an additive in a detergent composition, in the treatment of cellulose containing fabrics, in the treatment of pulp and paper and in the treatment of starch for the production of high fructose corn-syrup or ethanol |
| 04/16/2009 | US20090098575 antiidiotypic, chimeric, humanized, monoclonal or polyclonal antibodies or faragments that specifically binds polypeptides having synthetase enzyme activity |
| 04/16/2009 | US20090098566 Method of synthesizing nucleic acid |
| 04/16/2009 | US20090098564 Quantifying in RNA of a blood sample, a level of RNA and comparing with control; allows for an immediate and accurate diagnostic/prognostic test for disease or to assess the effect of a particular treatment regimen |
| 04/16/2009 | US20090098563 Diagnosis of (a risk of) disease and monitoring of therapy |
| 04/16/2009 | US20090098550 Mri contrast agents and high-throughput screening by mri |
| 04/16/2009 | US20090098538 Prognostic and diagnostic method for disease therapy |
| 04/16/2009 | US20090098534 Full Karyotype Single Cell Chromosome Analysis |
| 04/16/2009 | US20090098528 Method for determining early HCV seroconversion |
| 04/16/2009 | US20090098301 Solid support having electrostatic layer and use thereof |
| 04/16/2009 | US20090098166 Chimeric MSP-based malaria vaccine |
| 04/16/2009 | US20090098164 Spore associated display |
| 04/16/2009 | US20090098120 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098119 Antidotes for factor xa inhibitors and methods of using the same |
| 04/16/2009 | US20090098112 Novel antibodies |
| 04/16/2009 | US20090098109 Compositions and Methods For Enhancing Neuronal Plasticity and Regeneration |
| 04/16/2009 | US20090098100 Hormonally up-regulated, neu-tumor-associated kinase |
| 04/16/2009 | US20090098083 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 04/16/2009 | US20090098056 Alpk1 gene variants in diagnosis risk of gout |
| 04/16/2009 | DE19520398B4 Magnetisches Pigment Magnetic pigment |
| 04/16/2009 | CA2702241A1 Methods and compositions for the diagnosis and treatment of esphageal adenocarcinomas |
| 04/16/2009 | CA2640985A1 Reagents and methods for detecting neisseria gonorrhoeae |
| 04/15/2009 | EP2048505A2 Method for early recognition of the seroconversion of an antibody to hepatitis C |
| 04/15/2009 | EP2048149A2 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid support |
| 04/15/2009 | EP2046995A2 Serum dna methylation screening for cancer |
| 04/15/2009 | EP2046994A2 Early detection and prognosis of colon cancers |
| 04/15/2009 | EP2046993A2 Rna silencing compositions and methods for the treatment of huntington's disease |
| 04/15/2009 | EP2046964A2 Transducible delivery of nucleic acids by reversible phosphotriester charge neutralization protecting groups |
| 04/15/2009 | EP2046954A2 NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT |
| 04/15/2009 | EP2046808A2 Methods and reagents for detecting hantavirus |
| 04/15/2009 | EP2046807A2 Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration |
| 04/15/2009 | EP2046806A2 Chimeric zinc finger recombinases optimized for catalysis by directed evolution |
| 04/15/2009 | EP2046369A2 Recombinant host for producing l-asparaginase ii |
| 04/15/2009 | EP1924591A4 Compositions and methods for purifying nucleic acids |
| 04/15/2009 | EP1754052A4 Peptide modulators of cellular phenotype and bi-nucleic acid fragment library |
| 04/15/2009 | EP1745129B1 Antibodies against canine pancreatic lipase |
| 04/15/2009 | EP1572904B1 Modified bace |
| 04/15/2009 | EP1483409B1 Method of error reduction in nucleic acid populations |
| 04/15/2009 | EP1417307B1 Oligonucleotide compositions and their use to induce apoptosis |
| 04/15/2009 | EP1203007B1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) and its receptor c-met |
| 04/15/2009 | EP1012267B1 An antisense oligonucleotide preparation method |
| 04/15/2009 | EP1003474B1 Method of treating dry eye disease with purinergic receptor agonists |
| 04/15/2009 | CN101410518A dsRNA compositions and methods for treating HPV infection |